Euclidean Capital LLC — 13F Holdings & Portfolio
CIK 1825034 · latest 13F-HR filed 2026-05-15
Euclidean Capital LLC manages $392.3M in 13F-reported U.S. long-equity assets across 10 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are VEU (62.09%), VTV (26.01%), INDA (4.41%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 2, added to 4, and trimmed 3.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$392.3M
Long-equity book
10
Distinct positions
2026-03-31
Filed 2026-05-15
+0 / −2 / ↑4 / ↓3
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- VANGUARD INTL EQUITY INDEX F$23.6M +10.7%
- ORIC PHARMACEUTICALS INC$4.4M +54.9%
- ALECTOR INC$771.6K +37.8%
- SURROZEN INC$572.7K +28.9%
Top Trims
- ISHARES TR-$2.7M -13.3%
- FOGHORN THERAPEUTICS INC-$975.7K -11.5%
- SURROZEN INC-$684 -20.0%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD INTL EQUITY INDEX F | VEU | 922042775 | $243.6M | 62.09% | 3,243,484 | SH |
| 2 | VANGUARD INDEX FDS | VTV | 922908744 | $102.0M | 26.01% | 520,000 | SH |
| 3 | ISHARES TR | INDA | 46429B598 | $17.3M | 4.41% | 369,600 | SH |
| 4 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $12.5M | 3.20% | 989,410 | SH |
| 5 | FOGHORN THERAPEUTICS INC | FHTX | 344174107 | $7.5M | 1.92% | 1,573,761 | SH |
| 6 | PMV PHARMACEUTICALS INC | PMVP | 69353Y103 | $3.3M | 0.83% | 2,627,643 | SH |
| 7 | ALECTOR INC | ALEC | 014442107 | $2.8M | 0.72% | 1,307,858 | SH |
| 8 | SURROZEN INC | SRZN | 86889P208 | $2.6M | 0.65% | 87,696 | SH |
| 9 | TENAYA THERAPEUTICS INC | TNYA | 87990A106 | $703.3K | 0.18% | 1,015,705 | SH |
| 10 | SURROZEN INC | SRZNW | 86889P117 | $2.7K | 0.00% | 170,833 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $392.3M | 10 | 0001012975-26-000442 |
| 2025-12-31 | 2026-02-17 | $369.5M | 12 | 0001012975-26-000154 |
| 2025-09-30 | 2025-11-14 | $238.0M | 11 | 0001012975-25-000761 |